Latest News about REGN
Recent news which mentions REGN
Will Moderna Stock Reach $500?
September 28, 2021
From Motley Fool
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
Breaking Down CRISPR Technology
September 28, 2021
From Motley Fool
3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
September 28, 2021
From Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Could AbbVie's New Collaboration Be a Blockbuster?
September 27, 2021
From Motley Fool
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
From Benzinga
CDC head overrules advisers to allow COVID-19 boosters be offered to at-risk workers, and Biden urges eligible to act fast
September 24, 2021
From MarketWatch
Here's Why I Bought This Recent Genetics IPO
September 22, 2021
From Motley Fool
Where to Invest $100 Right Now
September 22, 2021
From Motley Fool
NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?
September 21, 2021
From InvestorPlace
3 COVID Stocks to Buy in a Bear Market
September 21, 2021
From Motley Fool
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
September 20, 2021
From Benzinga
AbbVie's Pain Is Sanofi's and Regeneron's Gain
September 18, 2021
From Motley Fool
Smart Investors Are Watching This Trend Right Now
September 16, 2021
From Motley Fool
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
From InvestorPlace
Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push
September 15, 2021
From MarketWatch
Breaking Down The Inflation Numbers Draws Attention To Oil Prices
September 15, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
September 15, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
From Motley Fool
Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?
September 11, 2021
From Motley Fool
3 Stocks to Watch in September
September 10, 2021
From Motley Fool
Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?
September 09, 2021
From Motley Fool
3 Hot Stocks to Buy in September
September 07, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.